Pancreatic Cancer Research

ResearcherShandong Provincial QianFoShan HospitalActive in the last 2 years

Wei Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5546-4572; OpenAlex author ID A5000048962. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 2 papers · 2023: 2 papers · 2024: 1 paper

Papers 5

  1. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2. Co-author DOI 10.3389/fimmu.2024.1347683↗
  2. Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem. Co-author DOI 10.1016/j.jconrel.2023.07.061↗
  3. Unveiling the role of regulatory T cells in the tumor microenvironment of pancreatic cancer through single-cell transcriptomics and in vitro experiments. Co-author DOI 10.3389/fimmu.2023.1242909↗
  4. Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis. Co-author DOI 10.1371/journal.pone.0269612↗
  5. The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis. Co-author DOI 10.21037/tcr-21-2803↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunfang Xu · 4 shared papers, 2022–2024 · strength 0.77
  2. Minyue Yin · 2 shared papers, 2022 · strength 0.37
  3. Zhen Weng · 2 shared papers, 2022 · strength 0.37
  4. Hao Yang · 1 shared paper, 2024 · strength 0.21
  5. Xinyuan Zhou · 1 shared paper, 2023 · strength 0.20
  6. Meirong Huo · 1 shared paper, 2023 · strength 0.20
  7. Qiang Li · 1 shared paper, 2023 · strength 0.19
  8. Qi Wang · 1 shared paper, 2023 · strength 0.19
  9. Wenjia Zhang · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.